Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$986K Buy
7,674
+1,252
+19% +$147K 0.05% 185
2026
Q1
$773K Sell
6,422
-29,253
-82% -$3.38M 0.05% 198
2025
Q4
$3.76M Buy
35,675
+1,685
+5% +$158K 0.14% 173
2025
Q3
$2.85M Buy
33,990
+6,745
+25% +$556K 0.11% 196
2025
Q2
$2.16M Sell
27,245
-1,522
-5% -$121K 0.08% 227
2025
Q1
$2.58M Buy
28,767
+566
+2% +$52.8K 0.1% 195
2024
Q4
$2.81M Buy
28,201
+1,161
+4% +$120K 0.1% 182
2024
Q3
$3.07M Sell
27,040
-5,286
-16% -$628K 0.1% 191
2024
Q2
$4M Buy
32,326
+30,390
+1,570% +$3.91M 0.14% 177
2024
Q1
$255K Buy
+1,936
New +$239K 0.17% 61
2023
Q3
Sell
-1,820
Closed -$210K 78
2023
Q2
$210K Buy
+1,820
New +$207K 0.15% 69

Other funds holding MRK

F/M Investments's MRK Position: Q2 2026 in Review

F/M Investments increased its Merck (MRK) stake by 19% in Q2 2026, buying an estimated $147K and bringing the position to 7,674 shares worth $986K. The position accounts for 0.05% of the portfolio, ranked #185.

F/M Investments first reported a position in MRK in Q2 2023 and has held it in 11 quarters since. The position peaked at $4M in Q2 2024. 3,836 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • F/M Investments held 7,674 shares of Merck worth $986K as of Q2 2026.
  • F/M Investments bought 1,252 Merck shares in Q2 2026, an estimated $147K.
  • Merck made up 0.05% of F/M Investments's portfolio in Q2 2026, its #185 holding.
  • F/M Investments first reported a position in Merck in Q2 2023 and has held it in 11 quarters since.
  • F/M Investments's Merck position peaked at $4M in Q2 2024.
  • 3,836 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.